Role of PACAP in Migraine Headaches

J Gordon Millichap

doi:10.15844/pedneurbriefs-28-4-3

Role of PACAP in Migraine Headaches

Pediatric Neurology Briefs

Volume 28 (2014): Issue 4

By: J Gordon Millichap

Open Access

|Apr 2014

Abstract

Investigators at Danish Headache Centre, University of Copenhagen, Glostrup, Denmark, studied the incidence of migraine during and after intravenous infusion of pituitary adenylate cyclase-activating polypeptide-38 (PACAP38) and vasoactive intestinal polypeptide (VIP) in 22 female migraine patients without aura (mean age 24 years [range 19-36]).

References

Amin FM Hougaard A Schytz HW Asghar MS Lundholm E Parvaiz AI Investigation of the pathophysiological mechanisms of migraine attacks induced by pituitary adenylate cyclase-activating polypeptide-38 Brain 2014 Mar 137 Pt 3 779 94 10.1093/brain/awt369 24501094
Open DOI Search in Google Scholar Back to article
Vécsei L Tuka B Tajti J Role of PACAP in migraine headaches Brain 2014 Mar 137 Pt 3 650 1 10.1093/brain/awu014 24549810
Open DOI Search in Google Scholar Back to article
Markovics A Kormos V Gaszner B Lashgarara A Szoke E Sandor K Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice Neurobiol Dis 2012 Jan 45 1 633 44 10.1016/j.nbd.2011.10.010 22033344
Open DOI Search in Google Scholar Back to article

Articles in this issue

DOI: https://doi.org/10.15844/pedneurbriefs-28-4-3 | Journal eISSN: 2166-6482

Journal RSS Feed

Language: English

Page range: 27 - 28

Published on: Apr 1, 2014

Published by: Pediatric Neurology Briefs Publishers

In partnership with: Paradigm Publishing Services

Keywords:

Polypeptide-38,

Migraine Patients,

VIP-Induced Dilatation

© 2014 J Gordon Millichap, published by Pediatric Neurology Briefs Publishers
This work is licensed under the Creative Commons Attribution 4.0 License.

Volume 28 (2014): Issue 4